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Introduction: Postoperative bacterial endophthalmitis is a devastating complication of cataract 
surgery. Methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis is rare. Recent 
debate over MRSA screening in United Kingdom (UK) National Health Service (NHS) hospital 
services has implications for cataract patients and ophthalmology services.
Aims: To discuss issues for clinical practice as based on reflective experience at a UK district 
general NHS hospital in relation to care of MRSA-positive cataract patients.
Methods: Retrospective case series and reflective practice.
Results: Three cases presented highlight practice points around cataract patients   colonized with 
MRSA. Known or determined MRSA-colonized patients should be treated with anti-microbial 
agents at time of cataract surgery known to be active against MRSA. Preventative treatment with 
intracameral vancomycin or intravenous teicoplanin alongside appropriate topical treatments 
may be of merit. Importantly fluoroquinolones, often prescribed by cataract surgeons, may have 
a selective effect favoring the proliferation of MRSA.
Conclusion: MRSA screening may cause unnecessary delays in cataract care and may represent 
a patient safety concern in its own right. Patients colonized with MRSA may safely undergo 
cataract surgery provided there is no evidence of periorbital infection and provided appropri-
ate infection control and antibiotic prophylaxis measures are used. The well-prepared cataract 
surgeon needs to be aware of developments in infection control and should liaise with local 
clinical microbiology colleagues in relation to bacterial resistance to antibiotics.
Keywords: methicillin-resistant Staphylococcus aureus (MRSA), endophthalmitis, 
screening
Introduction
Postoperative endophthalmitis is an uncommon but devastating complication of 
cataract surgery with reported rates of between 0.06% and 0.25%.1 Incidence rates 
of   methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis are poorly 
defined, but there are recent reports of clusters of such cases leading to discussion.2,3 
Screening and management policies for MRSA carriers in cataract care in the UK are 
variable.4 Three patients treated for cataract at our hospital, and who were colonized 
with MRSA, serve to highlight practice points around the care of such patients. Rel-
evant issues are reflected upon.
Case 1
A 70-year-old female was referred by her general practitioner (GP) with dense cataract 
in the right eye and proliferative diabetic retinopathy in the left eye. Visual acuity was Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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1/60 in the right eye and 6/60 in the left eye. Co-morbidities 
included congestive cardiac failure, peripheral vascular dis-
ease, chronic obstructive pulmonary disease, chronic kidney 
disease, eczema, insulin-dependent diabetes mellitus, and 
previous pulmonary embolus. She lived alone and smoked 
20 cigarettes daily. Her GP had approached us as he was con-
cerned that the patient had been denied ophthalmic surgery for 
several years at 2 nearby ophthalmic institutions solely due to 
her MRSA colonization and despite failed MRSA eradication 
regimens. The patient was house-bound because of her severe 
visual impairment. Uneventful day care phacoemulsification 
cataract surgery was performed in our department under local 
anesthesia through a clear corneal incision following a course 
of attempted MRSA eradication treatment with nasal mupiro-
cin and chlorhexidine baths to satisfy infection control policy. 
The patient was deliberately not re-swabbed prior to cataract 
surgery. Infection control measures included provision of a 
single room and placement last on the operating list. Povodine-
iodine periocular and conjunctival sac disinfection was used 
during the surgery and subconjunctival cefadrine was injected 
at the end of the procedure. Peri-operatively the patient was 
given 400 mg of teicoplanin by intravenous bolus injection. 
Post-operative antibiotic regimen consisted of levofloxacin 
drops 4 times a day for 4 weeks. Visual acuity recovered to 6/60 
due to co-existent diabetic maculopathy previously masked by 
the severe lens opacity.
Case 2
A 72-year-old male in residential nursing home care pre-
sented with advanced cataracts and visual loss. This patient 
was a known to be colonized with MRSA. Attempted MRSA 
eradication regimen consisting of nasal mupirocin and chlo-
rhexidine baths was implemented for 5 days prior to surgery, 
and infection control measures included provision of a single 
room and placement last on the operating list.   Povodine-iodine 
periocular and conjunctival sac disinfection was used. 
Uneventful sutureless phacoemulsification cataract surgery 
was undertaken as a day case. Subconjunctival cefadrine was 
injected at the end of the procedure. Post-  operative prescrip-
tions included tobramycin/  dexamethasone drops 4 times daily 
for 1 month and ofloxacin drops 4 times daily for 1 week. The 
post  operative visual acuity was 6/9. Mild anterior uveitis was 
present 2-weeks postoperatively which settled spontaneously 
on the topical steroid regimen prescribed. No evidence of 
infection was encountered. The patient later underwent suc-
cessful day case left cataract surgery with implementation 
of the same pre- and peri-operative   measures. Post-operative 
visual acuity in the left eye improved to 6/18.
Case 3
An 88-year-old lady with active MRSA-infected chronic leg 
ulcers was referred with advanced vision loss, counting fin-
gers in the right eye and 3/60 in the left eye. Significant cata-
racts were present, with co-existent dry age-related macular 
degeneration (AMD) in the right eye and neovascular AMD 
in the left eye. The patient was listed for left cataract surgery 
and a course of intravitreal ranibizumab as a day case. Infec-
tion control measures included provision of a single room 
and placement last on the operating list.   Pre-operatively the 
patient was prescribed levofloxacin drops 4 times daily for 
4 days, and povodine-iodine periocular and conjunctival sac 
disinfection was applied prior to surgery. Peri-operatively 
the patient was given intravenous teicoplanin 400 mg bolus. 
She underwent phacoemulsification surgery and intravitreal 
ranibizumab injection in her left eye at the same session. 
Subconjunctival cephradine was injected at completion of 
surgery followed by levofloxacin drops 2 hourly for 2 days 
and then 4 hourly for 5 days along with prednisolone 0.5% 
drops 4 times daily for 4 weeks. The visual acuity improved 
to 6/24. The macular edema from wet AMD resolved.
Discussion
We report 3 patients with MRSA-colonization and advanced 
visual loss who successfully underwent cataract surgery and 
which illustrate several practice points. Firstly, the unproven 
benefits of screening for MRSA in cataract patients may be 
outweighed by treatment delays and harm to the patient. 
Secondly, patients colonized with MRSA infection may 
safely undergo cataract surgery provided that the appropriate 
pre peri- and post-operative infection control measures and 
adequate antibiotic prophylaxis are used.
There has been debate over the role of MRSA screen-
ing in ophthalmology. In late 2006 the UK Department of 
Health recommended that all elective admissions in England 
should be screened for MRSA and if found positive should 
then undergo decolonization regime.5 Following comments 
by the Royal College of Ophthalmologists and others, it was 
clarified in refreshed operational guidance to the National 
Health Service (NHS) in early 2008 that day-case ophthal-
mology patients in the English NHS did not have to undergo 
routine MRSA screening.6,7 A survey of UK ophthalmology 
departments undertaken in September 2005 demonstrated 
significant variability surrounding local MRSA screening 
practices.4 Following a consideration of available evidence 
The MRSA Screening Pathfinder Programme in Scotland has 
not recommended universal MRSA screening requirements in 
its Interim Report.8 MRSA screening is not currently required   Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1225
MRSA and cataract surgery
in England or Scotland for day-care ophthalmology patients, 
but is required for admitted ophthalmic patients.7,9
Given the large numbers of cataract surgeries undertaken 
in many developed economies the logistics and resource 
implications of screening such large numbers of patients for 
MRSA carrier status and subsequent decolonization are not 
insignificant. Furthermore it is possible that delays imposed 
by MRSA screening diktats and repeated decolonization regi-
mens may be an added unintended patient safety concern as 
our Case 1 demonstrates. Of relevance, the delays in Case 1 
occurred during the period in 2006–2008 when MRSA screen-
ing policy in ophthalmic departments in some NHS Trusts 
were perhaps in states of transition. In addition, such MRSA 
screening and eradication policies may have little bearing on 
ophthalmic clinical outcomes. We are unaware of any stud-
ies that demonstrate a reduced risk of endophthalmitis in 
the presence of MRSA screening and eradication regimens. 
This is possibly due to the relative infrequency of MRSA 
endophthalmitis, but also possibly as MRSA colonization 
is commonly identified by sampling patients’ anterior nares 
and perineal regions. Such screening sampling methods may 
not reflect the periocular bacterial flora relevant to cataract 
surgery and risk of endophthalmitis.10,11 In addition there are 
no proven eradication regimens, very few studies having used 
controls or randomization.12 Finally existing current MRSA 
eradication/decolonization regimes are only partially effective. 
Rohr et al13 reported that 64% of affected patients were cleared 
of MRSA colonization after a course of eradication treatment 
with intranasal mupirocin ointment and chlorhexidine baths, 
indicating such a regime was ineffective in nearly one-third 
of such patients. If no active periorbital infection is present 
on clinical examination, proceeding with cataract surgery on 
clinical grounds is, in our opinion, probably safe despite know-
ing MRSA screening status or not. Likewise postponement of 
cataract surgery on the day of surgery should be considered 
if any signs of peri-orbital infection are found to be present 
despite the potential disappointment to patients of cancella-
tion on the day of surgery, and despite this being regarded as 
a ‘negative indicator’ by performance managers.
In addition, with the emergence of community acquired 
MRSA many MRSA-colonized patients may not have the 
patient risk factors required to trigger screening on hospital-
ization. Rao and colleagues14 screened all patients admitted 
through a hospital Emergency Department for MRSA car-
riage and demonstrated that 15.5% of the patients found to 
be positive for MRSA did not have recognized risk factors 
such as recent hospital admission, advanced age or care 
home residency.
Various measures have been suggested to reduce the risk 
of postoperative bacterial endophthalmitis, the Royal College 
of Ophthalmologists15 and American Academy of Ophthal-
mology16 recommend pre-operative conjunctival irrigation 
with 5% povodine iodine as prophylaxis against infection. 
The European Society of Cataract and Refractive Surgeons 
(ESCRS) Endophthalmitis Study Group investigators 
reported reductions in postoperative endophthalmitis inci-
dence following cataract surgery in patients receiving intrac-
ameral cefuroxime injection in addition to povodine iodine.17 
Resultantly, practice surveys show that   intracameral cefu-
roxime injection has become increasingly popular amongst 
UK cataract surgeons.18 However cefuroxime is not effective 
against MRSA19 and as is being found in clinical practice 
in cases of MRSA endophthalmitis.20   Fourth-  generation 
fluoroquinolone antimicrobial agents, such as moxifloxacin 
or gatifloxin, offer an alternative option for topical and intra-
cameral antibiotic prophylaxis and are favored in practice 
surveys undertaken amongst many members of the American 
Society of Cataract and Refractive Surgeons.21 However 
fluoroquinolone-resistant S. aureus is also an emerging trend 
of bacterial resistance.22–26 Of potential clinical relevance 
to cataract surgeons favoring   topical fluorquinolones, such 
antibiotics have also been shown to exert a strong selective 
pressure favoring the growth of MRSA organisms.27,28 In a 
recent case series of 33 cases of culture-positive postoperative 
endophthalmitis following cataract surgery,22 all 6 cases of 
MRSA endophthalmitis had received topical fluoroquinolone 
antibiotics (moxifloxacin, gatifloxacin or levofloxacin) 2 or 3 
days prior to cataract surgery and in the postoperative period. 
Importantly, none of the isolated organisms in the case series 
from Deramo and colleagues were sensitive to any fluoro-
quinolone antibiotic; but all 6 organisms were sensitive in 
vitro to both gentamicin and vancomycin.22 These resistance 
patterns are also in keeping with several studies reporting in 
vitro bacterial resistance to the newer-generation fluoroqui-
nolones ciprofloxacin, ofloxacin, and levofloxacin in corneal 
and conjunctival MRSA infections.23,24 A review of cases 
of postoperative endophthalmitis treated over an 11-year 
period at Wills Eye Hospital25 demonstrated changes over 
time in the in vitro susceptibility of bacteria isolated from 
the vitreous of patients following cataract surgery, with 
significant increases in resistance in such bacterial isolates 
to ciprofloxacin and ofloxacin. Importantly, resistance to 
vancomycin remained unchanged throughout the study time 
period in that series. While pre-operative topical antibiotic 
prophylaxis in cataract surgery is commonplace, it has been 
associated with significantly increased risk of development Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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of infection in a survey from Germany.29 Sub-conjunctival 
antibiotic injections at completion of cataract surgery remain 
popular in the UK. A reduction of postoperative endophthal-
mitis with this approach has been demonstrated in a nested 
case-control study from Western Australia.30 As all MRSA 
organisms responsible for postoperative endophthalmitis in 
the cases series from Deramo et al22 were sensitive to gen-
tamicin or vancomycin antibiotics, it may also perhaps be 
inferred that such antibiotics may also be of potential merit 
in cataract patients who are colonized with MRSA.
In conclusion, while it may be of some merit to know 
whether patients are colonized with MRSA or not, only 
patient periorbital/conjunctival colonization is likely to 
be clinically relevant to cataract surgeons when aiming to 
provide optimal outcomes for cataract surgery patients. 
Patients with active peri-ocular or conjunctival infection 
should not undergo intraocular surgery. MRSA screening 
and associated eradication regimes may cause unnecessary 
delays in some ophthalmic patients. It is reasonable, in our 
opinion, to treat cataract patients with known MRSA carrier 
status with nasal mupirocin, and to advise the recommended 
bathing measures as well as consider administering antibiot-
ics known to be active against MRSA, such as gentamicin, 
vancomycin or teicoplanin. Fluoroquinolone antibiotics 
should be discouraged in this patient group. Advice from 
a clinical microbiologist with knowledge of current local 
bacterial antibiotic sensitivity patterns is of merit. In the era 
of both health care and community acquired MRSA infec-
tions, particular vigilance and attention to infection control 
is required in all cases of cataract surgery, whether or not 
patients have been screened for, or carry, recognized risk 
factors for MRSA colonization.
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